ArticleJournal of clinical neurology (Seoul, Korea)2023

Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial.

Byung-Kun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.